电科院(300215) - 2025 Q3 - 季度财报
2025-10-28 12:05
Financial Performance - The company's operating revenue for Q3 2025 was ¥137,510,272.52, a decrease of 9.01% compared to the same period last year[4] - The net profit attributable to shareholders was ¥3,193,949.62, down 72.17% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥16,243.93, a decline of 99.83%[4] - Year-to-date revenue reached ¥375,000,400.11, reflecting a 19.08% decrease compared to the previous year[4] - Total operating revenue decreased to ¥375,000,400.11 from ¥463,410,985.93, representing a decline of approximately 19% year-over-year[19] - Net profit for the period was a loss of ¥22,716,866.12, compared to a profit of ¥16,493,033.25 in the previous period, indicating a significant downturn[20] - The company's operating profit turned negative at -¥19,906,458.36, compared to a positive operating profit of ¥13,921,990.95 in the prior year[20] - Other comprehensive income after tax was ¥816,925.58, with total comprehensive income amounting to -¥21,899,940.54 for the period[21] - The company reported a basic and diluted earnings per share of -¥0.03, compared to ¥0.02 in the previous period[21] Assets and Liabilities - The total assets as of September 30, 2025, were ¥2,494,163,708.20, a decrease of 6.54% from the end of the previous year[4] - Total current assets amount to ¥546,858,241.94, an increase from ¥512,799,951.31 at the beginning of the period[16] - The total non-current assets decreased to ¥1,947,305,466.26 from ¥2,155,803,568.35[17] - The total liabilities decreased to ¥522,465,633.71 from ¥671,260,034.51, a reduction of about 22%[18] - Total equity attributable to shareholders decreased to ¥1,961,185,761.24 from ¥1,987,332,477.82, a decline of approximately 1.3%[18] Cash Flow - Cash flow from operating activities for the year-to-date was ¥219,329,672.55, an increase of 6.24%[4] - Cash flow from operating activities was ¥422,881,796.97, down from ¥478,209,229.31 in the previous period[22] - Net cash flow from operating activities was $219.33 million, compared to $206.44 million in the previous period[23] - Cash outflow from investing activities reached $229.09 million, significantly higher than $50.68 million last year[23] - Net cash flow from investing activities was -$190.39 million, compared to -$10.29 million in the previous period[23] - Cash inflow from financing activities was $100 million, down from $170 million year-over-year[23] - Net cash flow from financing activities was -$96.42 million, compared to -$168.78 million last year[23] - The ending cash and cash equivalents balance was $279.86 million, down from $370.54 million in the previous period[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 30,007[12] - The largest shareholder, Hu Chun, holds 33.27% of shares, totaling 249,223,791 shares[12] - The second largest shareholder, China Inspection and Certification Group Testing Technology Co., Ltd., holds 25.40% of shares, totaling 190,250,000 shares[12] Investments and Financial Assets - The company reported a significant increase in trading financial assets, which rose by 139.35% to ¥89,962,803.46 due to the purchase of wealth management products[8] - The investment income for the first nine months of 2025 was ¥1,974,433.63, an increase of 178.15% compared to the same period last year[10] - The fair value change income was ¥5,069,480.86, a significant recovery from a loss of ¥5,175,929.97 in the previous year[10] Operational Highlights - The company successfully conducted a short-circuit withstand test for a 400MVA transformer, marking a significant achievement in domestic testing capabilities[15] - The company plans to release new products and technologies, focusing on market expansion and strategic acquisitions[15] Research and Development - Research and development expenses decreased to ¥33,878,033.01 from ¥40,106,039.75, a decline of approximately 15% year-over-year[20] Accounting and Auditing - The company did not undergo an audit for the third quarter financial report[24] - The company will implement new accounting standards starting in 2025[24]
锋尚文化(300860) - 2025 Q3 - 季度财报
2025-10-28 12:05
Financial Performance - Q3 2025 revenue was ¥7,538,318.48, a decrease of 95.96% year-over-year, while year-to-date revenue was ¥198,152,440.26, down 47.95% compared to the same period last year[5] - The net profit attributable to shareholders was a loss of ¥4,822,653.69 for Q3 2025, representing a decline of 370.91%, and a year-to-date loss of ¥8,636,720.90, down 60.81% year-over-year[5] - The basic and diluted earnings per share for Q3 2025 were both -¥0.03, a decrease of 422.58% compared to the same period last year[5] - Total operating revenue for the current period was $198,152,440.26, a decrease of 47.9% compared to $380,713,406.02 in the previous period[20] - Net profit for the current period was $9,100,975.50, a decline of 61.6% from $23,728,946.40 in the previous period[20] - Total comprehensive income for the current period was 9,102,162.10, compared to 23,728,946.40 in the previous period, reflecting a decrease of about 61.7%[21] - Basic earnings per share were 0.05 for the current period, down from 0.12 in the previous period, representing a reduction of 58.3%[21] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was -¥23,450,881.41, a decline of 202.73% year-over-year, primarily due to reduced sales collections[9] - The company's cash and cash equivalents increased by 39.85% to ¥752,094,243.77 compared to the end of 2024, due to changes in cash management[9] - Total current assets decreased to $3,221,068,301.60 from $3,394,320,162.16, reflecting a reduction of 5.1%[18] - Total non-current assets decreased to $248,325,115.44 from $275,988,121.52, a decline of 10.1%[18] - Total assets decreased to $3,469,393,417.04 from $3,670,308,283.68, representing a decrease of 5.5%[19] - Cash and cash equivalents at the end of the period were 746,776,149.42, an increase from 364,702,955.81 in the previous period[24] Shareholder Information - The total number of common shareholders at the end of the reporting period was 13,983[11] - The top shareholder, Sha Xiaolan, holds 42.13% of shares, totaling 80,440,919 shares[11] - The company holds 2,480,620 shares in its repurchase account, accounting for 1.30% of total shares[11] - The top ten shareholders do not participate in the securities lending business[11] - The company has not disclosed any related party transactions among shareholders[11] Corporate Actions - The company plans to use up to RMB 15 billion of idle raised funds for cash management, effective for 12 months from the approval date[12] - The company will use its own funds to pay part of the project costs and replace them with raised funds, ensuring no impact on project progress[13] - The company will cancel repurchased shares, reducing total share capital from 190,931,343 shares to 188,450,723 shares[13] - The company revised its articles of association, eliminating the supervisory board and transferring its powers to the audit committee of the board[14] - Zheng Junjie was elected as the employee representative director for the fourth board term[15] Operating Costs - The company reported a significant reduction in operating costs, with costs down 41.63% to ¥153,821,072.91 year-to-date[9] - Total operating costs amounted to $226,706,481.88, down 33.0% from $338,669,162.85 in the prior period[20] - Research and development expenses for the current period were $23,502,283.58, down 17.8% from $28,565,233.51 in the previous period[20] Investment Activities - The net cash flow from investing activities was ¥293,273,060.96, a significant increase of 210.66% year-over-year, attributed to cash recovery from management[9] - Cash inflow from investment activities was 5,899,729,719.35, up from 4,504,617,371.73 in the previous period, indicating an increase of approximately 30.9%[24] - Cash outflow from investment activities was 5,606,456,658.39, compared to 4,769,642,918.12 in the previous period, showing an increase of about 17.5%[24] Liabilities and Equity - Total liabilities decreased to $300,680,083.21 from $462,655,901.29, a reduction of 35.0%[18] - Total equity attributable to shareholders decreased to $3,148,209,974.31 from $3,185,225,277.47, a decline of 1.2%[18] Audit Status - The third quarter financial report was not audited[25]
中达安(300635) - 2025 Q3 - 季度财报
2025-10-28 12:05
Financial Performance - The company's revenue for Q3 2025 was ¥166,880,565.83, representing a 1.91% increase year-over-year, while the year-to-date revenue decreased by 5.03% to ¥468,961,898.56[4] - The net profit attributable to shareholders for Q3 2025 was a loss of ¥867,605.46, a 63.48% increase in loss compared to the same period last year, with a year-to-date net profit of ¥980,151.19, down 56.30%[4] - The basic earnings per share for Q3 2025 was -¥0.0062, a 64.37% increase in loss year-over-year, while the diluted earnings per share was -¥0.0064, a 63.22% increase in loss[4] - Total operating revenue for the current period was ¥468,961,898.56, a decrease of 5.5% from ¥493,816,468.65 in the previous period[26] - Net profit for the current period was ¥3,769,289.30, a decline of 32.2% compared to ¥5,560,165.38 in the previous period[27] - Earnings per share (EPS) decreased to ¥0.0071 from ¥0.0165, reflecting a decline of 57.4%[28] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥1,380,541,502.73, reflecting a 0.82% increase from the end of the previous year[4] - As of September 30, 2025, the company's total assets amounted to CNY 1,380,541,502.73, an increase from CNY 1,369,362,378.68 at the beginning of the period[22] - The company's total current liabilities increased to CNY 803,540,111.66 from CNY 765,186,670.07, representing an increase of approximately 5.5%[24] - The long-term borrowings decreased to CNY 137,469,000.00 from CNY 165,873,000.00, a reduction of about 17.1%[24] Cash Flow - The company's cash flow from operating activities for the year-to-date was -¥10,127,853.12, showing a 90.51% improvement compared to the same period last year[4] - Cash flow from operating activities showed a net outflow of ¥10,127,853.12, an improvement from a net outflow of ¥106,742,104.72 in the previous period[28] - The net cash flow from financing activities for the year-to-date was -¥12,248,901.75, a 115.91% decrease compared to the same period last year[8] - The net cash flow from financing activities was -$12.25 million, contrasting with a positive $77.01 million in the previous period, indicating a significant downturn[29] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,906[10] - The largest shareholder, Jinan Likong Disen Equity Investment Partnership, holds 10.01% of shares, totaling 14,031,261 shares[10] - The second-largest shareholder, Wu Junye, owns 9.12% of shares, amounting to 12,778,864 shares[10] - The total number of restricted shares at the end of the reporting period is 19,717,905, with various conditions for unlocking[14] - The company has a total of 20,373,968 restricted shares, with 701,225 shares released during the reporting period[14] Operational Changes - The company has completed the registration changes regarding capital increase and business scope, as approved in meetings held on January 17 and February 7, 2025[15] - The company is planning to issue shares to specific investors, which may lead to a change in actual control, with trading suspended from June 23 to June 25, 2025, due to this uncertainty[16] - The company appointed Li Haijie as the new Vice President and Board Secretary, effective from June 9, 2025[18] - The company has completed the termination of the acquisition of 100% equity in Shandong Liuhou Information Consulting Co., Ltd., with all share transfer payments settled[20] - The company is in the process of issuing A-shares to specific investors, pending approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission[19] Investment and Expenses - The investment income for Q3 2025 decreased by 53.11% to ¥734,315.66 compared to the same period last year[8] - Research and development expenses were ¥37,258,620.98, down 7.4% from ¥40,089,516.26 in the previous period[26] - Sales expenses increased to ¥10,476,059.80, up 27% from ¥8,261,532.00 in the previous period[26] - The company reported a significant increase in credit impairment losses, amounting to ¥7,559,874.08, compared to the previous year[8] - The company reported a significant increase in credit impairment losses to ¥7,559,874.08 from a reversal of ¥1,547,265.63 in the previous period[27] Other Information - The company has not disclosed any new product developments or market expansion strategies in the current reporting period[10] - The company's cash and cash equivalents decreased to CNY 154,108,073.20 from CNY 182,707,598.32, reflecting a decline of approximately 15.7%[23] - The accounts receivable balance was CNY 187,608,052.48, slightly down from CNY 191,395,067.59, indicating a decrease of about 2.0%[23] - The company's non-current assets totaled CNY 401,326,786.35, a slight decrease from CNY 408,601,630.17 at the beginning of the period[24] - The capital reserve increased to CNY 86,888,791.27 from CNY 84,693,079.27, reflecting an increase of approximately 2.6%[24] - The company's third-quarter financial report was not audited, which may affect the reliability of the reported figures[30]
华厦眼科(301267) - 2025 Q3 - 季度财报
2025-10-28 12:05
Financial Performance - The company's operating revenue for Q3 2025 was ¥1,132,883,729.40, representing a year-on-year increase of 0.13%[5] - The net profit attributable to shareholders for Q3 2025 was ¥151,682,862.05, a decrease of 2.37% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥145,557,749.72, showing a slight increase of 0.20% year-on-year[5] - Total operating revenue for the current period reached ¥3,271,797,099.40, an increase of 2.8% compared to ¥3,181,879,566.30 in the previous period[19] - Net profit for the current period was ¥456,066,099.99, compared to ¥442,334,462.70 in the previous period, indicating a growth of 3.1%[20] Assets and Liabilities - The total assets as of September 30, 2025, amounted to ¥8,163,130,801.02, reflecting a growth of 3.02% from the end of the previous year[5] - The company's total assets increased to ¥8,163,130,801.02 from ¥7,924,043,231.64, representing a growth of 3.0%[17] - Total liabilities rose to ¥1,954,785,761.96, up from ¥1,900,587,269.74, marking an increase of 2.8%[17] - The company's equity attributable to shareholders increased to ¥5,998,641,817.34 from ¥5,794,409,772.57, reflecting a growth of 3.5%[17] Cash Flow - The cash flow from operating activities for the year-to-date period was ¥698,110,689.68, an increase of 3.61%[5] - Net cash flow from operating activities was CNY 698,110,689.68, up from CNY 673,755,479.24 in the previous period[23] - Cash inflow from operating activities totaled CNY 3,331,087,546.30, slightly higher than CNY 3,314,706,537.36 last year[22] - Cash outflow from investing activities was CNY 9,327,290,666.34, compared to CNY 7,464,214,439.71 in the previous period, resulting in a net cash flow from investing activities of -CNY 2,866,790,736.89[23] - The company experienced a net cash outflow from financing activities of -CNY 391,334,969.96, an improvement from -CNY 439,006,413.53 in the previous period[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,229[12] - The largest shareholder, Huaxia Medical Investment (Xiamen), holds 30.45% of shares, totaling 255,764,011 shares[12] - The second-largest shareholder, Su Qingcan, holds 30.41% of shares, totaling 255,405,989 shares[12] - The company has a total of 470,247,758 shares controlled by Su Qingcan and related parties, representing 63.00% of total shares[12] - The company has not disclosed any other shareholders with related party relationships or acting in concert[12] Expenses and Income - The company's financial expenses increased by 33.20% year-on-year, primarily due to the use of temporarily idle funds for financial products, resulting in reduced bank interest income[10] - The company reported a significant increase of 671.22% in trading financial assets, totaling ¥2,960,920,870.16, attributed to cash management strategies[10] - The asset disposal income increased by 521.00% year-on-year, mainly due to gains from the disposal of right-of-use assets[10] - The company experienced a 42.77% decrease in non-operating expenses, primarily due to reduced charitable donations[10] - Research and development expenses for the current period were ¥46,537,186.58, down from ¥53,903,578.99, a decrease of 13.7%[20] - The company reported an investment income of ¥31,396,054.12, compared to ¥45,033,384.18 in the previous period, showing a decline of 30.4%[20] Dividends - The company distributed a cash dividend of RMB 2.20 per 10 shares, totaling RMB 183,143,875.20 for the 2024 profit distribution[13] Cash and Cash Equivalents - The cash and cash equivalents decreased from RMB 3,487,699,580.40 to RMB 915,034,696.29[15] - The cash and cash equivalents increased to ¥323,526,661.10 from ¥240,471,990.33, a rise of 34.5%[17] - Cash and cash equivalents at the end of the period stood at CNY 909,526,296.29, down from CNY 1,084,478,851.40[23] Other Financial Metrics - The weighted average return on equity for the reporting period was 2.56%, a decrease of 0.15% compared to the same period last year[5] - Total comprehensive income for the period reached CNY 455,441,542.57, an increase from CNY 442,438,879.20 in the previous period[21] - Basic and diluted earnings per share increased to CNY 0.52 from CNY 0.50[21] - The financial report for the third quarter was not audited[25]
康龙化成(300759) - 2025 Q3 - 季度财报


2025-10-28 12:05
康龙化成(北京)新药技术股份有限公司 2025 年第三季度报告 证券代码:300759 证券简称:康龙化成 公告编号:2025-061 康龙化成(北京)新药技术股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告 中财务信息的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 康龙化成(北京)新药技术股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入(元) | 3,64 ...
星帅尔(002860) - 2025 Q3 - 季度财报
2025-10-28 12:05
Financial Performance - Revenue for Q3 2025 reached ¥609,132,314.01, an increase of 29.08% year-over-year[5] - Net profit attributable to shareholders was ¥55,327,821.62, up 4.49% compared to the same period last year[5] - Total operating revenue for the current period reached ¥1,741,531,291.49, an increase of 14.93% compared to ¥1,514,773,368.51 in the previous period[19] - Net profit for the current period was ¥179,343,681.28, representing a 20.77% increase from ¥148,496,392.48 in the previous period[20] - Total comprehensive income amounted to ¥179,343,681.28, an increase from ¥148,496,392.48 in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,641,233,607.32, reflecting a 2.86% increase from the end of the previous year[5] - The company's total assets increased to ¥3,641,233,607.32, compared to ¥3,539,901,873.00 in the previous period, reflecting a growth of 2.87%[17] - Total liabilities decreased to ¥1,327,243,479.94 from ¥1,674,915,745.97, indicating a reduction of 20.73%[17] - Shareholder equity increased by 24.48% year-over-year, amounting to ¥2,271,237,842.69[5] - The equity attributable to shareholders of the parent company rose to ¥2,271,237,842.69, up from ¥1,824,569,447.66, marking a growth of 24.59%[17] Cash Flow - Operating cash flow net amount increased by 1,438.07% year-to-date, totaling ¥79,218,176.69[5] - Cash inflow from operating activities was ¥1,430,325,338.64, down from ¥1,603,489,134.82 in the previous period[24] - Net cash flow from operating activities improved to ¥79,218,176.69 from a negative ¥5,920,315.35 in the previous period[24] - Cash inflow from investment activities totaled ¥2,911,656,644.25, significantly higher than ¥895,436,053.03 in the previous period[24] - Cash flow from financing activities resulted in a net outflow of ¥206,607,047.82, compared to a net inflow of ¥73,204,147.58 in the previous period[24] Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,704[10] - The largest shareholder, Chen Lijuan, holds 23.78% of the shares, totaling 85,552,673 shares[10] - The top ten shareholders include both individual and institutional investors, with the second-largest shareholder holding 10.81%[10] - The company has a repurchase account holding 7,567,400 shares among the top ten shareholders[10] - The company has not reported any changes in the number of preferred shareholders or their holdings[12] Expenses and Income - Investment income rose by 322.96% year-over-year, attributed to increased financial management income[9] - The company reported a 57.02% decrease in financial expenses compared to the same period last year, mainly due to reduced convertible bond interest[9] - Total operating costs amounted to ¥1,556,639,332.22, up 13.14% from ¥1,375,917,663.38 in the prior period[19] - Research and development expenses for the current period were ¥47,087,056.33, slightly higher than ¥44,661,382.46 in the previous period[20] Receivables and Inventory - The company experienced a significant increase in receivables financing, up 601.72% since the beginning of the year, due to the receipt of bank acceptance bills[9] - Accounts receivable increased to ¥821,769,304.76 from ¥739,104,178.74, reflecting a growth of about 11.1%[15] - Inventory levels rose to ¥364,667,018.60 from ¥342,744,280.99, indicating an increase of approximately 6.4%[15] - The total amount of accounts receivable financing increased significantly to ¥196,171,636.17 from ¥27,955,992.42, marking a substantial rise[15] Cash Management - The company has a cash balance of ¥493,835,629.81, down from ¥589,098,301.40 at the beginning of the period, representing a decrease of approximately 16.2%[15] - The ending cash and cash equivalents balance was ¥359,770,365.51, slightly up from ¥335,808,891.43 in the previous period[24] - The company received ¥20,270,101.59 in tax refunds, compared to ¥5,807,616.06 in the previous period[23] - The company reported a significant increase in cash received from investment recoveries, totaling ¥2,901,860,000.00, compared to ¥890,120,589.04 in the previous period[24] Future Outlook - The company plans to expand its market presence and invest in new technologies to drive future growth[17]
东北证券(000686) - 2025 Q3 - 季度财报
2025-10-28 12:05
Financial Performance - Total operating revenue for Q3 2025 reached ¥1,815,114,500.18, an increase of 47.89% compared to ¥1,227,319,444.88 in the same period last year[5] - Net profit attributable to shareholders was ¥635,999,062.82, representing an 86.24% increase from ¥341,486,991.71 year-on-year[5] - Basic earnings per share rose to ¥0.27, an 80.00% increase compared to ¥0.15 in the previous year[5] - The company's net profit for the period reached CNY 1,099,557,537.61, an increase of 110.62% compared to CNY 522,053,003.23 in the previous period[12] - Net profit for the period was RMB 1,099,557,537.61, up 110.5% from RMB 522,053,003.23 in the prior period[36] - The earnings per share (EPS) for the period was RMB 0.46, compared to RMB 0.20 in the previous period, representing a 130% increase[37] Assets and Liabilities - Total assets at the end of the reporting period were ¥110,057,780,062.95, a 23.62% increase from ¥89,025,653,094.93 at the end of the previous year[5] - The total assets increased to RMB 110,057,780,062.95 from RMB 89,025,653,094.93, reflecting a growth of 23.6%[34] - The total liabilities increased by 34.78%, with other liabilities reaching CNY 12,159,096,423.03 compared to CNY 9,021,162,526.39 previously[12] - The total liabilities rose to RMB 89,626,736,976.78, up from RMB 69,440,144,341.30, indicating a growth of 29.2%[34] Cash Flow - The company’s cash flow from operating activities showed a negative figure of -¥1,768,228,088.45, a decline of 128.94% compared to the previous year[5] - The net cash flow from operating activities was -2,606,332,666.69 RMB, a significant decrease from 8,127,761,566.16 RMB in the previous period[39] - The cash flow from operating activities showed a total inflow of 15,576,231,874.25 RMB, compared to 10,576,853,721.87 RMB previously[39] - The net cash flow from financing activities was 6,701,730,736.23 RMB, a turnaround from -4,116,249,436.42 RMB in the previous period[40] Investments - The company reported a significant increase in lending funds, which rose by 32.01% to ¥18,463,039,011.16 from ¥13,985,668,804.77[10] - The derivative financial assets increased by 33.74% to ¥563,879,442.61, up from ¥421,638,212.52[10] - The company reported a significant increase in other equity instrument investments, which surged by 36,783.56% to ¥3,415,273,781.50 from ¥9,259,611.00[10] - The investment income for the period was RMB 1,204,638,260.04, an increase from RMB 1,061,006,949.76, reflecting a growth of 13.5%[36] Equity - The company’s total equity attributable to shareholders increased by 4.28% to ¥19,935,642,426.01 from ¥19,118,308,250.75 at the end of the previous year[5] - The company's total equity increased to RMB 20,431,043,086.17 from RMB 19,585,508,753.63, a growth of 4.3%[34] Regulatory and Corporate Actions - The company has maintained compliance with regulatory requirements for risk control indicators throughout the first three quarters of 2025[15] - The company issued three phases of short-term corporate bonds and three phases of subordinated bonds, with a total issuance scale of 37.5 billion RMB[23][24]. - The company completed the relocation of two business outlets during the reporting period, with the new addresses finalized on July 23, 2025, and September 19, 2025[22]. - The company plans to reduce the registered capital of its wholly-owned subsidiary Dongzheng Rongda Investment Co., Ltd. to 1 billion RMB, as approved on July 15, 2025[29]. - The first major shareholder, Jilin Yatai Group, intends to sell 20.81% of its shares to Changchun Urban Development Investment Holding Group Co., Ltd. and 9% to Changchun Financial Holding Group Co., Ltd.[26]. - The company’s board approved the dissolution of the asset custody department on August 26, 2025[21]. - The company experienced changes in its board of directors, with new non-independent directors elected on July 31, 2025[25]. - The company completed three additional business outlet relocations in October 2025[30]. - The company’s financial report as of September 30, 2025, is pending further details[31].
志特新材(300986) - 2025 Q3 - 季度财报
2025-10-28 12:00
江西志特新材料股份有限公司 2025 年第三季度报告 证券代码:300986 证券简称:志特新材 公告编号:2025-137 江西志特新材料股份有限公司 2025 年第三季度报告 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 3.第三季度财务会计报告是否经过审计 □是 否 1 江西志特新材料股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 □是 否 | | 本报告期 | 本报告期比上 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 年同期增减 | | 比上年同期增减 | | 营业收入(元) | 730,210,859.31 | 8.84% | 2, ...
铭科精技(001319) - 2025 Q3 - 季度财报
2025-10-28 12:00
Financial Performance - Revenue for Q3 2025 reached ¥342,407,682.25, an increase of 58.05% compared to the same period last year[5] - Net profit attributable to shareholders was ¥42,349,137.49, up 35.20% year-on-year[5] - Basic earnings per share for Q3 2025 were ¥0.2995, reflecting a growth of 35.21% compared to the previous year[5] - Total operating revenue for the current period reached ¥856,576,702.69, an increase of 27.5% compared to ¥671,454,074.91 in the previous period[24] - Net profit for the current period was ¥99,706,272.34, representing a 29.2% increase from ¥77,163,550.30 in the previous period[25] - Earnings per share (EPS) for the current period was ¥0.7009, compared to ¥0.5412 in the previous period, reflecting a 29.5% increase[26] - The company reported a total comprehensive income of ¥98,347,631.40, up from ¥78,666,812.07, marking a 25.0% increase[26] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥1,772,459,955.87, representing a 4.28% increase from the end of the previous year[5] - The company reported a total asset of RMB 1,772,459,955.87 as of September 30, 2025, an increase from RMB 1,699,644,667.61 at the beginning of the period[21] - The company’s total liabilities reached RMB 1,085,352,493.81, indicating a significant leverage position[21] - Total liabilities increased to ¥418,552,508.23, up from ¥387,188,851.37, indicating a growth of 8.4%[22] - The company’s total current liabilities rose to RMB 392,600,490.20 from RMB 360,778,309.10, reflecting an increase of about 8.5%[21] - The total non-current liabilities amounted to ¥25,952,018.03, slightly down from ¥26,410,542.27, a decrease of 1.7%[22] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥94,957,826.22, a significant increase of 127.99%[5] - Cash flow from operating activities was ¥660,818,857.61, compared to ¥629,460,170.64 in the previous period, showing a growth of 5.0%[28] - Net cash flow from operating activities was $94,957,826.22, an increase from $41,649,263.45 in the previous period, reflecting a significant improvement[29] - Cash received from tax refunds amounted to $10,130,419.92, compared to $2,276,953.80 previously, indicating improved tax recovery[29] - Cash paid to employees was $175,903,235.54, an increase from $154,723,932.00, reflecting higher personnel costs[29] - Cash paid for taxes was $31,573,012.44, slightly down from $33,890,719.21, suggesting a minor reduction in tax liabilities[29] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 18,241[13] - The largest shareholder, Xia Lurong, holds 35.02% of the shares, totaling 49,518,000 shares[13] Investments and Acquisitions - The company acquired 80% of Hiroshima Technology (Nanjing) Automotive Parts Co., Ltd. for RMB 66.717 million to enhance its supply chain integration and technology upgrade[15] - The company’s long-term equity investments increased to RMB 15,641,583.83 from RMB 14,510,763.73[20] Current Assets - Accounts receivable increased to RMB 398,412,631.94 from RMB 335,033,575.16, indicating a growth of approximately 18.9%[20] - Inventory of RMB 215,262,904.71, slightly up from RMB 209,337,173.55[20] - Other current assets surged by 459.92% to ¥113,373,828.19, primarily due to the reclassification of large transferable certificates of deposit[10] Financial Ratios - The company’s weighted average return on equity was 3.21%, an increase of 0.68% compared to the previous year[5]
云南能投(002053) - 2025 Q3 - 季度财报
2025-10-28 12:00
云南能源投资股份有限公司 2025 年第三季度报告 3.第三季度财务会计报告是否经过审计 □是 ☑否 1 证券代码:002053 证券简称:云南能投 公告编号:2025-130 云南能源投资股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 云南能源投资股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 本报告期比上年同期 | | 年初至报告期末比上 年初至报告期末 | | | | --- | --- | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | | | 营业收入(元) | 3 ...